微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 4.14% | -16.19% | -76.52% | 7/139 | 1.16% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 17.63% | 34.17% | 27.85% | 4/139 | 2.07% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 13.79% | 5.59% | 42.16% | 4/139 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 9.7% | 29.85% | 96.36% | 4/139 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 4.94% | 31.73% | -62.4% | 5/139 | 1.04% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 13.14% | -11.93% | 0.61% | 11/139 | 3.02% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 13.06% | 19.27% | 74.83% | 9/139 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 7.47% | 6.71% | 99.2% | 15/139 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 3.75% | 0% | -74.87% | 16/139 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 14.92% | 35.88% | 36.26% | 10/139 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 10.95% | -27.63% | 56.43% | 22/139 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 7% | 29.15% | 86.67% | 25/139 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 3.75% | -2.34% | -65.85% | 30/139 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 10.98% | -36.42% | -27.43% | 62/139 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 15.13% | 4.27% | 179.15% | 31/139 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 5.42% | -36.31% | 41.15% | 65/139 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 3.84% | 1.59% | -77.76% | 39/139 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 17.27% | 19.27% | 19.02% | 48/139 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 14.51% | 12.66% | 70.51% | 40/139 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 8.51% | 25.33% | 125.13% | 48/139 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 3.78% | 33.57% | -73.9% | 41/139 | 6.18% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 14.48% | 3.06% | 12.42% | 65/139 | 25.47% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 12.88% | -0.23% | 89.69% | 46/139 | 19.63% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 6.79% | -16.17% | 139.93% | 59/139 | 15.03% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 2.83% | -32.94% | -79.86% | 28/139 | 3.37% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 14.05% | -6.71% | 8.83% | 58/139 | 14.24% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 12.91% | -6.11% | 59.38% | 20/139 | 10.37% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 8.1% | -7.22% | 91.94% | 24/139 | 6.65% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 4.22% | 11.94% | -71.98% | 12/139 | 2.68% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 15.06% | -13.89% | 9.53% | 53/139 | 12.87% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 13.75% | -15.7% | 57.5% | 12/139 | 7.11% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 8.73% | -32.33% | 131.57% | 11/139 | 3.2% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 3.77% | 2% | -78.44% | 17/139 | 2.61% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 17.49% | -0.51% | 7.23% | 37/139 | 13.76% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 16.31% | 2% | 26.43% | 6/139 | 9.4% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 12.9% | 85.08% | -26.62% | 6/139 | 5.88% | XD基蛋生 | 23.11% | 行业排名> |
| 2016-12-31 | 17.58% | 24.95% | 24.95% | 28/139 | 16.11% | XD基蛋生 | 11.34% | 行业排名> |